Newsletters

The European Medicines Agency (EMA) publishes newsletters to provide updates on various topics to patients, healthcare professionals and the pharmaceutical industry.

Human medicines highlights, published monthly, contains key information on human medicines and changes to regulatory processes in the past month. These highlights do not cover all the Agency's activities in the area of human medicines.

EMA provides an RSS feed of the human medicines highlights. To subscribe, use the below link and follow our user guide on how to subscribe to RSS feeds:

• Human Medicines Highlights newsletter

EMA does not collect any personal data from you when you subscribe to this RSS feed.

The newsletter for micro-, small- and medium-sized enterprises (SMEs), published four times a year, provides key updates to SMEs on the European regulatory environment.

For older editions, see the Newsletter archive.

• Report on the 10th anniversary of the SME initiative

What's new in pharmacovigilance, published four times a year, updates qualified persons for pharmacovigilance on guidance, regulations and events.

The Clinical Trials Information System (CTIS) highlights, published quarterly in 2021, provides key updates on the evolvement of CTIS.

To subscribe, write to ct.communication@ema.europa.eu.

The Veterinary Medicines Regulation highlights, published every two months in 2021, provides an update on progress towards implementing the new Regulation.

To subscribe, write to vetchange.programme@ema.europa.eu.